14 new biological drugs were approved by the FDA in 2019. These drugs were either peptidomimetic, antibody or oligonucleotide scaffolds. It is important to store some of these scaffolds under cold temperatures to preserve their therapeutic function. However, storing under cold temperatures is a challenging supply-chain process and adds to the cost of the entity. Our guest today, Dr. Balaji Sridhar has invented a technology to address this challenge and preserve the function of these biological scaffolds at room temperature.

Dr. Balaji V. Sridhar is the CEO and co-founder of Nanoly Bioscience Inc., a life sciences company, based in Denver, Colorado. He invented the Nanoshield technology to solve the cold-challenge while working on his MD.PhD. Nanoly has won numerous awards including Intel’s Top Social Innovation, NASA and Space Frontier Foundation’s Top 10 New Technology Companies for Space, Airbus’ Materials and Manufacturing Award, and an NIH SBIR grant. You can find more information on Nanoly through this podcast and at Nanoly.info.